慢性重型肝炎MELD评分分析  

The Analysis of MELD in the 156 Severe Hepatitis

作　　者：赵燕芹[1] 胡肖兵[1] 李粤平[1] 周颖[1] 

机构地区：[1]广州市第八人民医院,广州510060

出　　处：《现代临床医学生物工程学杂志》2004年第5期396-397,共2页Journal of Modern Clinical Medical Bioengineering

摘　　要：目的　由于国内外对重型肝炎的诊断存在差异性 ,故引入终末期肝病评估模式MELD .通过对慢性重型肝炎临床资料进行MELD评分 ,评估病情严重程度和预后 ,以验证MELD评分系统在国内的适用性 .方法　整理 15 6例慢性重型肝炎患者临床资料进行MELD评分 ,评估慢性重型肝炎的严重程度和预后 .结果　慢性重型肝炎死亡组MELD评分分值明显高于存活组 (p <0 .0 1) ,MELD评分分值与实际病死率呈正相关 ,MELD分值 >4 0分者 ,3个月死亡率为 10 0 % .结论　MELD评分系统在国内是适用的 ,可引入临床应用 .慢性重型肝炎患者MELD评分分值与病情严重程度和预后有关 .Objective Due to different diagnostic of the severe hep at itis between China and out of China, it is necessary to import the model for end -sta ge liver disease (MELD). Through MELD scoring for the chronic severe hepatitis c linical material, evaluate the patient's condition and prognosis to verify the a pplicability of MELD system in Chinese. Methods The clinical da ta of 156 chronic severe hepatitis were collected and evaluated by MELD scoring system to evaluate the chronic severe hepatitis patient's condition and prognosi s. Results The scores of the dead group were higher remarkable than those of the surviving group. The scores of MELD had positive correlation w ith the actual fatality rate. When the scores of MELD was larger than 40 all dea d in 3 months. Conclusions MELD is suitable for Chinese. ME LD scoring system can be popularized in clinic. The scores of MELD in the chroni c severe hepatitis are correlated to the patient's condition and prognosis.

关 键 词：MELD评分 慢性重型肝炎 预后 病情严重程度 患者 临床应用 诊断 系统 验证 国内 

分 类 号：R575.1[医药卫生—消化系统]